1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologics & Biosimilars Revenue
1.4 Market Analysis by Type
1.4.1 Global Biologics & Biosimilars Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotic
1.4.3 Enzyme
1.4.4 Hormone
1.4.5 Non-Patented Biological Reagents
1.4.6 Other
1.5 Market by Application
1.5.1 Global Biologics & Biosimilars Market Share by Application: 2021-2026
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Biologics & Biosimilars Market
1.8.1 Global Biologics & Biosimilars Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Biologics & Biosimilars Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Biologics & Biosimilars Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Biologics & Biosimilars Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Biologics & Biosimilars Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Biologics & Biosimilars Sales Volume Market Share by Region (2015-2020)
3.2 Global Biologics & Biosimilars Sales Revenue Market Share by Region (2015-2020)
3.3 North America Biologics & Biosimilars Sales Volume
3.3.1 North America Biologics & Biosimilars Sales Volume Growth Rate (2015-2020)
3.3.2 North America Biologics & Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Biologics & Biosimilars Sales Volume
3.4.1 East Asia Biologics & Biosimilars Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Biologics & Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Biologics & Biosimilars Sales Volume (2015-2020)
3.5.1 Europe Biologics & Biosimilars Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Biologics & Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Biologics & Biosimilars Sales Volume (2015-2020)
3.6.1 South Asia Biologics & Biosimilars Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Biologics & Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Biologics & Biosimilars Sales Volume (2015-2020)
3.7.1 Southeast Asia Biologics & Biosimilars Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Biologics & Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Biologics & Biosimilars Sales Volume (2015-2020)
3.8.1 Middle East Biologics & Biosimilars Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Biologics & Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Biologics & Biosimilars Sales Volume (2015-2020)
3.9.1 Africa Biologics & Biosimilars Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Biologics & Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Biologics & Biosimilars Sales Volume (2015-2020)
3.10.1 Oceania Biologics & Biosimilars Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Biologics & Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Biologics & Biosimilars Sales Volume (2015-2020)
3.11.1 South America Biologics & Biosimilars Sales Volume Growth Rate (2015-2020)
3.11.2 South America Biologics & Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Biologics & Biosimilars Sales Volume (2015-2020)
3.12.1 Rest of the World Biologics & Biosimilars Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Biologics & Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Biologics & Biosimilars Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Biologics & Biosimilars Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Biologics & Biosimilars Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Biologics & Biosimilars Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Biologics & Biosimilars Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Biologics & Biosimilars Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Biologics & Biosimilars Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Biologics & Biosimilars Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Biologics & Biosimilars Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Biologics & Biosimilars Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Biologics & Biosimilars Sales Volume Market Share by Type (2015-2020)
14.2 Global Biologics & Biosimilars Sales Revenue Market Share by Type (2015-2020)
14.3 Global Biologics & Biosimilars Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Biologics & Biosimilars Consumption Volume by Application (2015-2020)
15.2 Global Biologics & Biosimilars Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Biologics & Biosimilars Business
16.1 fizer
16.1.1 fizer Company Profile
16.1.2 fizer Biologics & Biosimilars Product Specification
16.1.3 fizer Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Novartis
16.2.1 Novartis Company Profile
16.2.2 Novartis Biologics & Biosimilars Product Specification
16.2.3 Novartis Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 AbbVie
16.3.1 AbbVie Company Profile
16.3.2 AbbVie Biologics & Biosimilars Product Specification
16.3.3 AbbVie Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Roche
16.4.1 Roche Company Profile
16.4.2 Roche Biologics & Biosimilars Product Specification
16.4.3 Roche Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Novo Nordisk
16.5.1 Novo Nordisk Company Profile
16.5.2 Novo Nordisk Biologics & Biosimilars Product Specification
16.5.3 Novo Nordisk Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Amgen
16.6.1 Amgen Company Profile
16.6.2 Amgen Biologics & Biosimilars Product Specification
16.6.3 Amgen Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Lilly
16.7.1 Lilly Company Profile
16.7.2 Lilly Biologics & Biosimilars Product Specification
16.7.3 Lilly Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Johnson & Johnson
16.8.1 Johnson & Johnson Company Profile
16.8.2 Johnson & Johnson Biologics & Biosimilars Product Specification
16.8.3 Johnson & Johnson Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Sanofi
16.9.1 Sanofi Company Profile
16.9.2 Sanofi Biologics & Biosimilars Product Specification
16.9.3 Sanofi Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Merck
16.10.1 Merck Company Profile
16.10.2 Merck Biologics & Biosimilars Product Specification
16.10.3 Merck Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Gelgen Biopharma
16.11.1 Gelgen Biopharma Company Profile
16.11.2 Gelgen Biopharma Biologics & Biosimilars Product Specification
16.11.3 Gelgen Biopharma Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Hospira
16.12.1 Hospira Company Profile
16.12.2 Hospira Biologics & Biosimilars Product Specification
16.12.3 Hospira Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 3sbio
16.13.1 3sbio Company Profile
16.13.2 3sbio Biologics & Biosimilars Product Specification
16.13.3 3sbio Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Sandoz
16.14.1 Sandoz Company Profile
16.14.2 Sandoz Biologics & Biosimilars Product Specification
16.14.3 Sandoz Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Biotech Pharma
16.15.1 Biotech Pharma Company Profile
16.15.2 Biotech Pharma Biologics & Biosimilars Product Specification
16.15.3 Biotech Pharma Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Changchun High Tech
16.16.1 Changchun High Tech Company Profile
16.16.2 Changchun High Tech Biologics & Biosimilars Product Specification
16.16.3 Changchun High Tech Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Mylan
16.17.1 Mylan Company Profile
16.17.2 Mylan Biologics & Biosimilars Product Specification
16.17.3 Mylan Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Teva
16.18.1 Teva Company Profile
16.18.2 Teva Biologics & Biosimilars Product Specification
16.18.3 Teva Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 CP Guojian Pharmacy
16.19.1 CP Guojian Pharmacy Company Profile
16.19.2 CP Guojian Pharmacy Biologics & Biosimilars Product Specification
16.19.3 CP Guojian Pharmacy Biologics & Biosimilars Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Biologics & Biosimilars Manufacturing Cost Analysis
17.1 Biologics & Biosimilars Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Biologics & Biosimilars
17.4 Biologics & Biosimilars Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Biologics & Biosimilars Distributors List
18.3 Biologics & Biosimilars Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Biologics & Biosimilars (2021-2026)
20.2 Global Forecasted Revenue of Biologics & Biosimilars (2021-2026)
20.3 Global Forecasted Price of Biologics & Biosimilars (2015-2026)
20.4 Global Forecasted Production of Biologics & Biosimilars by Region (2021-2026)
20.4.1 North America Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
20.4.3 Europe Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
20.4.7 Africa Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
20.4.9 South America Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Biologics & Biosimilars Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Biologics & Biosimilars by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Biologics & Biosimilars by Country
21.2 East Asia Market Forecasted Consumption of Biologics & Biosimilars by Country
21.3 Europe Market Forecasted Consumption of Biologics & Biosimilars by Countriy
21.4 South Asia Forecasted Consumption of Biologics & Biosimilars by Country
21.5 Southeast Asia Forecasted Consumption of Biologics & Biosimilars by Country
21.6 Middle East Forecasted Consumption of Biologics & Biosimilars by Country
21.7 Africa Forecasted Consumption of Biologics & Biosimilars by Country
21.8 Oceania Forecasted Consumption of Biologics & Biosimilars by Country
21.9 South America Forecasted Consumption of Biologics & Biosimilars by Country
21.10 Rest of the world Forecasted Consumption of Biologics & Biosimilars by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer